Aurigene Hiring: Ph.D. Scientist for Pharmaceutical Development of Biologics (mAbs & ADCs)

Aurigene Discovery Technologies Limited, a development-stage biotech company focused on novel therapies for cancer and inflammatory diseases, and a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd., is urgently seeking a highly skilled individual for the role of Scientist in Pharmaceutical Development.

The successful candidate will play a critical role in advancing Aurigene’s portfolio of precision oncology, oral immune checkpoint inhibitors, and Th-17 pathway programs, with a primary focus on large molecule development.

💼 Job Details

Category	Information
Post Title	Scientist – Pharmaceutical Development
Location	Bangalore (India)
Industry Type	Biotechnology/Pharmaceutical R&D
Experience	4-6 years of relevant experience
Education	Ph.D. (in a relevant pharmaceutical/biotechnology science)
Application Deadline	October 15, 2025
Application Email	apoorva_s@aurigene.com / rajesh_m@aurigene.com

🔬 Core Expertise and Responsibilities

This is a highly specialized role requiring expertise in the development, scale-up, and manufacturing of complex biological drug products.

Focus on Biologics Development

Drug Product Development: Significant experience in the development, scale-up, and manufacturing of drug products for Monoclonal Antibodies (mAbs), bi-specific/tri-specific antibodies, and Antibody Drug Conjugates (ADCs) (New Biological Entities – NBE).
Specialized Delivery Systems: Hands-on experience in developing parenteral delivery systems, including complex forms like Nanoparticulate delivery systems and Lipid-based delivery systems.

Pre-Formulation and Pre-Clinical Studies

Characterization: Proficiently execute pre-formulation studies for mAbs and ADCs, including detailed physicochemical & Solid-State characterization.
In Silico Interpretation: Proficiency in interpreting and strategically utilizing in silico output regarding mAb developability to guide experimental design.
Preclinical Formulation: Planning and executing preclinical formulation development to effectively support crucial Pharmacokinetic (PK), efficacy, and toxicology (tox) studies.

Scale-Up, GMP, and NCE Support

Clinical Formulation: Planning and executing the formulation development of NBEs from the mAb and ADC platforms specifically for human clinical studies.
Scale-Up & Tech Transfer: Developing and executing robust strategies for scale-up and technology transfer of mAb and ADC drug products to manufacturing facilities.
GMP Coordination: Coordinating and executing the production of mAb and ADC drug products under GMP set up for clinical trials, ensuring meticulous documentation.
NCE Bioavailability: Supporting the development of enabling formulations (e.g., lipid-based, nanoparticulate, polymeric systems) aimed at improving the biopharmaceutical properties and bioavailability of traditional New Chemical Entities (NCEs).
Documentation & Compliance: Preparing detailed protocols, guidelines, and SOPs for lab equipment, instruments, and processes, and ensuring strict adherence to safety, health, and environment systems.